Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alzheimer's Disease Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alzheimer's Disease Drugmarket, defines the market attractiveness level of Alzheimer's Disease Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alzheimer's Disease Drug industry, describes the types of Alzheimer's Disease Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alzheimer's Disease Drug market and the development prospects and opportunities of Alzheimer's Disease Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alzheimer's Disease Drug market in Chapter 13.
By Player:
Johnson & Johnson
Merz Pharma
Allergan
Lundbeck
Daiichi Sankyo
Novartis
Pfizer
Eisai
By Type:
Donepezil
Memantine
Rivastigmine
By End-User:
Early to Moderate Stages
Moderate to Severe Stages
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alzheimer's Disease Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alzheimer's Disease Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alzheimer's Disease Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alzheimer's Disease Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alzheimer's Disease Drug Market Analysis and Outlook to 2022
-
7.1 Global Alzheimer's Disease Drug Consumption (2017-2022)
-
7.2 United States Alzheimer's Disease Drug Consumption (2017-2022)
-
7.3 Europe Alzheimer's Disease Drug Consumption (2017-2022)
-
7.4 China Alzheimer's Disease Drug Consumption (2017-2022)
-
7.5 Japan Alzheimer's Disease Drug Consumption (2017-2022)
-
7.6 India Alzheimer's Disease Drug Consumption (2017-2022)
-
7.7 South Korea Alzheimer's Disease Drug Consumption (2017-2022)
8 Region and Country-wise Alzheimer's Disease Drug Market Analysis and Outlook to 2028
-
8.1 Global Alzheimer's Disease Drug Consumption Forecast (2022-2028)
-
8.2 United States Alzheimer's Disease Drug Consumption Forecast (2022-2028)
-
8.3 Europe Alzheimer's Disease Drug Consumption Forecast (2022-2028)
-
8.4 China Alzheimer's Disease Drug Consumption Forecast (2022-2028)
-
8.5 Japan Alzheimer's Disease Drug Consumption Forecast (2022-2028)
-
8.6 India Alzheimer's Disease Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Alzheimer's Disease Drug Consumption Forecast (2022-2028)
9 Global Alzheimer's Disease Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Alzheimer's Disease Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Donepezil Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Memantine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Rivastigmine Consumption and Growth Rate (2017-2022)
-
9.2 Global Alzheimer's Disease Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Early to Moderate Stages Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Moderate to Severe Stages Consumption and Growth Rate (2017-2022)
10 Global Alzheimer's Disease Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Alzheimer's Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Donepezil Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Memantine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alzheimer's Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Early to Moderate Stages Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Moderate to Severe Stages Consumption Forecast and Growth Rate (2022-2028)
11 Global Alzheimer's Disease Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alzheimer's Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alzheimer's Disease Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alzheimer's Disease Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alzheimer's Disease Drug Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Alzheimer's Disease Drug Product and Service
-
14.2 Merz Pharma
-
14.2.1 Merz Pharma Company Details
-
14.2.2 Merz Pharma Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merz Pharma Alzheimer's Disease Drug Product and Service
-
14.3 Allergan
-
14.3.1 Allergan Company Details
-
14.3.2 Allergan Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allergan Alzheimer's Disease Drug Product and Service
-
14.4 Lundbeck
-
14.4.1 Lundbeck Company Details
-
14.4.2 Lundbeck Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Lundbeck Alzheimer's Disease Drug Product and Service
-
14.5 Daiichi Sankyo
-
14.5.1 Daiichi Sankyo Company Details
-
14.5.2 Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Daiichi Sankyo Alzheimer's Disease Drug Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Alzheimer's Disease Drug Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Alzheimer's Disease Drug Product and Service
-
14.8 Eisai
-
14.8.1 Eisai Company Details
-
14.8.2 Eisai Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eisai Alzheimer's Disease Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alzheimer's Disease Drug
-
Figure Alzheimer's Disease Drug Picture
-
Table Global Alzheimer's Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer's Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer's Disease Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alzheimer's Disease Drug Consumption by Country (2017-2022)
-
Figure United States Alzheimer's Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Alzheimer's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure China Alzheimer's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Alzheimer's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure India Alzheimer's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alzheimer's Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Alzheimer's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alzheimer's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alzheimer's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alzheimer's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alzheimer's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alzheimer's Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Donepezil Consumption and Growth Rate (2017-2022)
-
Figure Global Memantine Consumption and Growth Rate (2017-2022)
-
Figure Global Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure Global Early to Moderate Stages Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate to Severe Stages Consumption and Growth Rate (2017-2022)
-
Figure Global Donepezil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Memantine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Early to Moderate Stages Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate to Severe Stages Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alzheimer's Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alzheimer's Disease Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Alzheimer's Disease Drug Product and Service
-
Table Merz Pharma (Foundation Year, Company Profile and etc.)
-
Table Merz Pharma Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merz Pharma Alzheimer's Disease Drug Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Alzheimer's Disease Drug Product and Service
-
Table Lundbeck (Foundation Year, Company Profile and etc.)
-
Table Lundbeck Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lundbeck Alzheimer's Disease Drug Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Alzheimer's Disease Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Alzheimer's Disease Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Alzheimer's Disease Drug Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Alzheimer's Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Alzheimer's Disease Drug Product and Service
-
